Concepedia

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

Mace L. Rothenberg, John G. Kuhn, Larry J. Schaaf, G I Rodriguez, S. Gail Eckhardt, Miguel A. Villalona‐Calero, David Rinaldi, L. A. Hammond, Stephanie Hodges, Anusha Sharma,

Annals of Oncology · 2001 · 44 citations · 25 references

DOI

Concepts

References

25

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet · 2000 · 3.3K citations

, , +13

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

Leonard B. Saltz, John V. Cox, Charles D. Blanke et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

, , +13

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

David Cunningham, Seppo Pyrhönen, R.D. James et al. · The Lancet · 1998 · 1.3K citations

, , +13

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

Philippe Rougier, Eric Van Cutsem, Emilio Bajetta et al. · The Lancet · 1998 · 993 citations

, , +15

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

Stephanie Green, Geoffrey R. Weiss · Investigational New Drugs · 1992 · 616 citations

, , +14